Am Fam Physician. 2022;105(3):324-326
Published online February 18, 2022.
Author disclosure: No relevant financial relationships.
Key Points for Practice
• Vaccination against hepatitis B is recommended for all adults up to 59 years of age.
• The 15- and 20-valent PCVs are recommended for all adults 65 years and older and younger adults with risk factors. Those who receive the 15-valent vaccine should also receive the 23-valent PPSV.
• In addition to adults older than 50 years, recombinant zoster immunization is recommended for people 19 years and older with immunosuppression.
From the AFP Editors
The 2022 adult and child/adolescent immunization schedules have been approved by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) and are accessible at https://www.aafp.org/family-physician/patient-care/prevention-wellness/immunizations-vaccines.html. These schedules now combine links to COVID-19 vaccination information, Vaccination Information Statements, adverse event reporting, and a QR code for online schedules. Notable changes to the child/adolescent schedule include the addition of dengue vaccine recommendations, whereas the adult schedule has been updated with the 15-and 20-valent pneumococcal conjugate vaccines (PCV15, PCV20) in place of the 13-valent pneumococcal conjugate vaccine (PCV13), recombinant zoster vaccine recommendations for immunocompromised adults, and changes to hepatitis B recommendations.
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
